ACTIVE

A.N.W. - SOFT

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

-5,6 k €

+51.5% YoY

Gross margin

4,1 k €

+296.3% YoY

Equity

28,2 k €

-16.5% YoY

What does A.N.W. - SOFT do?

A.N.W. - SOFT is a Private limited company incorporated in 1996. Its main activity is: Rental and operating of own or leased real estate. Its registered office is in Duffel.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0457.440.221

Incorporation

08/03/1996

Legal form

Private limited company

Registered office

Hoogstraat 294 box C
2570 Duffel · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

30/06/2025

Activities (NACE)

68201Rental and operating of own or leased real estate· main 68201Rental and operating of own or leased real estate

Signals

Positive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	4,1 k €	+296%	-2,1 k €	-116%	13,3 k €	-43.8%	23,7 k €	+365%	-8,9 k €	-137%	24 k €	-34.8%	36,8 k €	-51.5%	75,9 k €	+22.5%	62 k €	+44.0%	43 k €	-13.0%	49,5 k €	+21.7%	40,6 k €	-0.3%	40,8 k €	+127%	17,9 k €	-61.1%	46 k €	+7.6%	42,8 k €	-14.3%	49,9 k €	+51.4%	33 k €	-6.1%	35,1 k €
EBITDA	2,6 k €	+175%	-3,5 k €	-131%	11,2 k €	-48.2%	21,6 k €	+325%	-9,6 k €	-141%	23,4 k €	-36.1%	36,6 k €	-51.8%	75,9 k €	+38.0%	55 k €	+27.9%	43 k €	-13.0%	49,5 k €	+22.4%	40,4 k €	-0.9%	40,8 k €	+128%	17,9 k €	-61.1%	46 k €	+7.6%	42,8 k €	-14.3%	49,9 k €	+317%	12 k €	-3.3%	12,4 k €
Operating result	-5,5 k €	+52.6%	-11,6 k €	-1148%	-927,6 €	-107%	13,7 k €	+175%	-18,2 k €	-223%	14,8 k €	-47.2%	28 k €	-58.4%	67,3 k €	+76.6%	38,1 k €	+9.8%	34,7 k €	-15.0%	40,8 k €	+28.7%	31,7 k €	-1.2%	32,1 k €	+414%	6,2 k €	-80.5%	32 k €	-17.4%	38,7 k €	-13.7%	44,9 k €	+563%	6,8 k €	+13.5%	6 k €
Net result	-5,6 k €	+51.5%	-11,5 k €	-1621%	-666,6 €	-107%	9,9 k €	+157%	-17,3 k €	-244%	12 k €	-47.7%	23 k €	-45.4%	42,1 k €	+360%	-16,2 k €	-149%	33,4 k €	-20.0%	41,7 k €	+54.2%	27,1 k €	-38.0%	43,7 k €	+7507%	574,1 €	-98.4%	36,2 k €	-14.4%	42,3 k €	+45.3%	29,1 k €	+1.1%	28,8 k €	-3.7%	29,9 k €
Balance sheet
Equity	28,2 k €	-16.5%	33,8 k €	-86.2%	245,3 k €	-49.0%	481,3 k €	+2.1%	471,4 k €	-3.5%	488,7 k €	+2.5%	476,7 k €	+5.1%	453,7 k €	+10.2%	411,6 k €	-3.8%	427,8 k €	+8.5%	394,4 k €	+11.8%	352,7 k €	+8.3%	325,6 k €	+15.5%	281,9 k €	-41.4%	481,4 k €	+8.1%	445,2 k €	+10.5%	402,9 k €	+7.8%	373,8 k €	+8.3%	345,1 k €
Total assets	240,4 k €	-2.0%	245,2 k €	-4.3%	256,2 k €	-53.9%	555,1 k €	+2.0%	544,1 k €	-3.7%	564,8 k €	+1.6%	556,1 k €	+1.9%	545,5 k €	+5.2%	518,5 k €	-1.7%	527,5 k €	+5.5%	499,9 k €	+7.7%	464,3 k €	+4.8%	443,1 k €	+10.4%	401,2 k €	-17.2%	484,3 k €	+7.4%	450,9 k €	+10.3%	408,9 k €	+7.4%	380,8 k €	+8.4%	351,2 k €
Cash	27 k €	+13.9%	23,7 k €	-12.5%	27,1 k €	-87.1%	210,5 k €	+400%	42,1 k €	-70.6%	143 k €	+20.2%	119 k €	+95.3%	60,9 k €	+194%	20,7 k €	-92.7%	285,4 k €	+9.0%	261,9 k €	+72.1%	152,2 k €	-4.5%	159,3 k €	+30.7%	121,9 k €	+13.8%	107 k €	+303%	26,6 k €	-59.5%	65,7 k €	+87.5%	35 k €	-37.8%	56,3 k €
Debts	209,1 k €	+0.6%	207,9 k €	+2924%	6,9 k €	-89.9%	68,1 k €	-6.4%	72,7 k €	-4.5%	76,2 k €	-4.1%	79,4 k €	-13.5%	91,8 k €	-14.2%	107 k €	+7.3%	99,7 k €	-5.5%	105,5 k €	-5.5%	111,6 k €	-5.0%	117,4 k €	-1.5%	119,3 k €	+3900%	3 k €	-47.8%	5,7 k €	-5.0%	6 k €	-13.6%	6,9 k €	+13.8%	6,1 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 5 ended

Active mandates

STEANN PHARMA

Director · 0660.893.761

Represented by Anneleen De Swert

Active

Ended mandates

STEANN PHARMA

Director · since 01 décembre 2023 · 0660.893.761

Represented by Anneleen De Swert

Ended

NICOLE HORTENSIA JOSEPHA CELIS

Associate · since 08 mars 1996

Ended

WILLEM FRANS ELISABETH M DE SWERT

Manager · since 08 mars 1996

Ended

Willem De Swert

Director · until 01 décembre 2023

Ended

At this address

Other companies at this address

Company	CBE no.
Advocatenkantoor Nick Paeleman● Active	0719.581.929
STEANN PHARMA● Active	0660.893.761

Annual accounts

Full financial information

	2025	2024	2023	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/07/2024	01/07/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	18 months	12 months	12 months	12 months
Filing date	29/01/2026	31/12/2024	30/12/2023	29/08/2022	30/07/2021	29/07/2020
General meeting	01/12/2025	01/12/2024	01/12/2023	27/06/2022	28/06/2021	29/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	01/12/2025	29/01/2026	Dutch	PDF
Abridged model	30/06/2024	01/12/2024	31/12/2024	Dutch	PDF
Abridged model	30/06/2023	01/12/2023	30/12/2023	Dutch	PDF
Micro model	31/12/2021	27/06/2022	29/08/2022	Dutch	PDF
Micro model	31/12/2020	28/06/2021	30/07/2021	Dutch	PDF
Micro model	31/12/2019	29/06/2020	29/07/2020	Dutch	PDF
Micro model	31/12/2018	24/06/2019	12/07/2019	Dutch	PDF
Micro model	31/12/2017	25/06/2018	30/07/2018	Dutch	PDF
Abridged model	31/12/2016	26/06/2017	25/07/2017	Dutch	PDF
Abridged model	31/12/2015	27/06/2016	19/07/2016	Dutch	PDF
Abridged model	31/12/2014	29/06/2015	18/07/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	28/07/2014	Dutch	PDF
Abridged model	31/12/2012	24/06/2013	25/07/2013	Dutch	PDF
Abridged model	31/12/2011	25/06/2012	13/08/2012	Dutch	PDF
Abridged model	31/12/2010	27/06/2011	26/07/2011	Dutch	PDF
Abridged model	31/12/2009	28/06/2010	20/07/2010	Dutch	PDF
Abridged model	31/12/2008	29/06/2009	11/07/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	07/07/2008	Dutch	PDF
Abridged model	31/12/2006	29/06/2007	16/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 5 ended

Active mandates

STEANN PHARMA

Director · 0660.893.761

Represented by Anneleen De Swert

Active

Ended mandates

STEANN PHARMA

Director · since 01 décembre 2023 · 0660.893.761

Represented by Anneleen De Swert

Ended

NICOLE HORTENSIA JOSEPHA CELIS

Associate · since 08 mars 1996

Ended

WILLEM FRANS ELISABETH M DE SWERT

Manager · since 08 mars 1996

Ended

Willem De Swert

Director · until 01 décembre 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/12/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/04/2022
WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
PDF
Capital / shares25/03/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares19/10/2005
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-5,6 k €↑
2024
Annual accounts 2024-11,5 k €↓
2023
Annual accounts 2023-666,6 €↓
2021
Annual accounts 20219,9 k €↑
2020
Annual accounts 2020-17,3 k €↓
2019
Annual accounts 201912 k €↓
2018
Annual accounts 201823 k €↓
2017
Annual accounts 201742,1 k €↑
2016
Annual accounts 2016-16,2 k €↓
2015
Annual accounts 201533,4 k €↓
2014
Annual accounts 201441,7 k €↑
2013
Annual accounts 201327,1 k €↓
2012
Annual accounts 201243,7 k €↑
2011
Annual accounts 2011574,1 €↓
2010
Annual accounts 201036,2 k €↓
2009
Annual accounts 200942,3 k €↑
2008
Annual accounts 200829,1 k €↑
2007
Annual accounts 200728,8 k €↓
2006
Annual accounts 200629,9 k €
08/03/1996
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

A.N.W. - SOFT

Overview

What does A.N.W. - SOFT do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline